Approval · Notice of Compliance 26521 · 2021
RYTHMOL: Notice of Compliance 26521
Issued August 27, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26521
- Date
- August 27, 2021
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To add a new adverse reaction of acute generalized exanthematous pustulosis (AGEP) to the product monograph, and to convert the product monograph to 2020 format.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RYTHMOL | Not yet assigned | — |
Medicinal ingredients
- PROPAFENONE HCL 150 MG per TAB
- PROPAFENONE HCL 300 MG per TAB